Filing Details
- Accession Number:
- 0001232583-17-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-17 18:17:16
- Reporting Period:
- 2017-02-15
- Filing Date:
- 2017-02-17
- Accepted Time:
- 2017-02-17 18:17:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1628908 | Evolent Health Inc. | EVH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1232583 | Steve Wigginton | C/O Evolent Health, Inc. 800 N. Glebe Road, Suite 500 Arlington VA 22203 | Ceo, Valence Health | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2017-02-15 | 12,000 | $3.84 | 371,692 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2017-02-15 | 6,000 | $20.12 | 365,692 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2017-02-15 | 6,000 | $20.13 | 359,692 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Class A Common Stock (right to buy) | Disposition | 2017-02-15 | 12,000 | $0.00 | 12,000 | $3.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 435,680 | 2024-04-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016.
- The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.00-$20.25, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.00-$20.25, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Class A Common Stock Options exercised began vesting at a rate of 25% annually beginning October 1, 2014.
Billionaire Hedge Funds
